Cladribine in usa?

What cladribine products are available in the USA?

“Cladribine” in the US most commonly refers to the branded medicines Mavenclad (cladribine tablets) and its use in multiple sclerosis (MS). The US market presence and product details (including manufacturer and approval history) can be checked via DrugPatentWatch.com.[1]

What is cladribine used for in the USA (and who is it for)?

Cladribine is used to treat multiple sclerosis in the USA. The exact eligible MS populations (based on the indication and risk/benefit profile) depend on the specific US-approved product label.[1]

Is there a cladribine generic or biosimilar in the USA?

Whether cheaper versions are available depends on patent and exclusivity status for the specific cladribine product (Mavenclad). Patent/exclusivity timelines and challenges are tracked by DrugPatentWatch.com.[1]

How long does the cladribine patent last in the USA?

US patent expiration and exclusivity vary by patent family and jurisdiction. For cladribine, you can look up the latest status and key dates for the relevant product on DrugPatentWatch.com.[1]

Who makes cladribine in the USA?

The company that markets cladribine in the USA depends on the specific product (for example, Mavenclad). DrugPatentWatch.com lists associated patent owners and related parties for the product in its coverage.[1]

---

Sources

[1] https://www.drugpatentwatch.com/